These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23935478)

  • 1. Parameter trajectory analysis to identify treatment effects of pharmacological interventions.
    Tiemann CA; Vanlier J; Oosterveer MH; Groen AK; Hilbers PA; van Riel NA
    PLoS Comput Biol; 2013; 9(8):e1003166. PubMed ID: 23935478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
    Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
    Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation.
    Hijmans BS; Tiemann CA; Grefhorst A; Boesjes M; van Dijk TH; Tietge UJ; Kuipers F; van Riel NA; Groen AK; Oosterveer MH
    FASEB J; 2015 Apr; 29(4):1153-64. PubMed ID: 25477282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
    Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
    Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameter adaptations during phenotype transitions in progressive diseases.
    Tiemann CA; Vanlier J; Hilbers PA; van Riel NA
    BMC Syst Biol; 2011 Oct; 5():174. PubMed ID: 22029623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
    Breevoort SR; Angdisen J; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
    Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
    J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice.
    Grefhorst A; Parks EJ
    J Lipid Res; 2009 Jul; 50(7):1374-83. PubMed ID: 19287042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor activation induces the uptake of cholesteryl esters from high density lipoproteins in primary human macrophages.
    Bultel S; Helin L; Clavey V; Chinetti-Gbaguidi G; Rigamonti E; Colin M; Fruchart JC; Staels B; Lestavel S
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2288-95. PubMed ID: 18802017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCAAT/enhancer binding protein β deletion increases mitochondrial function and protects mice from LXR-induced hepatic steatosis.
    Rahman SM; Choudhury M; Janssen RC; Baquero KC; Miyazaki M; Friedman JE
    Biochem Biophys Res Commun; 2013 Jan; 430(1):336-9. PubMed ID: 23159614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.
    Wiersma H; Nijstad N; de Boer JF; Out R; Hogewerf W; Van Berkel TJ; Kuipers F; Tietge UJ
    Atherosclerosis; 2009 Sep; 206(1):141-7. PubMed ID: 19339012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.
    Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F
    J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
    Zanotti I; Potì F; Pedrelli M; Favari E; Moleri E; Franceschini G; Calabresi L; Bernini F
    J Lipid Res; 2008 May; 49(5):954-60. PubMed ID: 18252848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
    van Straten EM; van Meer H; Huijkman NC; van Dijk TH; Baller JF; Verkade HJ; Kuipers F; Plösch T
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1171-8. PubMed ID: 19724022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator.
    Ratni H; Blum-Kaelin D; Dehmlow H; Hartman P; Jablonski P; Masciadri R; Maugeais C; Patiny-Adam A; Panday N; Wright M
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1654-7. PubMed ID: 19231176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.
    van der Stoep M; Li Z; Calpe-Berdiel L; van der Sluis RJ; Saleh P; McKinnon HJ; Smit MJ; Korporaal SJ; Van Berkel TJ; Van Eck M; Hoekstra M
    Biochem Pharmacol; 2013 Dec; 86(11):1594-602. PubMed ID: 24095721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.